Ibuprofen-Caffeine Modulation of Retinal Endothelial Tip Cell Migration
布洛芬-咖啡因对视网膜内皮尖端细胞迁移的调节
基本信息
- 批准号:8883635
- 负责人:
- 金额:$ 24.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2018-09-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAnimal ModelAstrocytesAvastinBioinformaticsBiologicalBlindnessBrainCaffeineCellsChildhoodClinical PharmacologyClinical TrialsCuesDevelopmentDistressDrug InteractionsDrug KineticsDrug TransportEnzymesEpidemicExposure toExtracellular MatrixGenesGestational AgeGoalsGrowthHumanHyperoxiaHypoxiaIbuprofenImaging TechniquesInfantInjection of therapeutic agentInterventionLaboratoriesMethodologyMicrogliaModelingMolecularNeonatalNotch Signaling PathwayOxidative StressOxygenPainPharmaceutical PreparationsPharmacogenomicsPhasePremature InfantProtein IsoformsProteolysisProteomicsRNA InterferenceRattusReportingRetinalRetinal DetachmentRetinal DiseasesRetinal HemorrhageRetinopathy of PrematurityRiskRoleRuptureSignal TransductionStressSystemTechniquesTechnologyVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3Vascular Endothelial Growth Factorsangiogenesisbasebehavioral studycell motilitycell typeclinically relevantdriving forcedrug metabolismexperiencefightinghigh riskinsightjagged1 proteinmigrationneonatenotch proteinnovelnovel strategiespreventreceptorresearch studyresponseuptake
项目摘要
Retinopathy of prematurity (ROP) is afflicts as much as 50% of all extremely low gestational age neonates (ELGANs, <28 weeks/<1250g). Ibuprofen and caffeine have been shown to decrease the risk of severe ROP in ELGANs and in animal models. Using unique techniques developed in our laboratory, we will examine the specific effects on human retinal microvascular endothelial tip cells (ECs), the driving force behind aberrant angiogenesis. We will study their dynamic interaction with astrocytes, their selection, activation, and migration during oxidative stress. More importantly, we will examine the efficacy of ibuprofen and/or caffeine in preventing their activation and reducing their capacity to sense angiogenic cues. The overarching goal of this proposal is to study the behavior of EC tip cells and their relationship with astrocytes in the setting of oxidative stress (hyperoxia/hypoxia cycling); and to determine whether ibuprofen coadministered with caffeine will preserve fip cell quiescence. Using state-of-the-art bioanalytics, proteomics, pharmacogenomics, bioinformatics, and imaging techniques, we will use three interrelated specific aims: 1) to examine the relationship between human retinal microvascular ECs and human brain astrocytes in normoxia and in oxidative stress (brief hyperoxia/hypoxia cycling). We will focus on VEGF and ECM proteolysis, VEGF release and increased gradient; tip cell activation, release and recapture of VEGF, and migration; and VEGF and Notch signaling mechanisms; 2) to establish the roles of VEGFR-2, VEGFR-3, NP-1, Notch 1, D1I4, and Jagged 1 on tip cell selection, activation and migration using small interference RNA
(SiRNA) knockdown of these specific genes in human retinal microvascular ECs. We will study the influence of astrocytes; and 3) to determine whether ibuprofen potentiated with caffeine will protect and preserve normal human retinal microvascular EC and astrocyte growth and function in oxidative stress. We will use state-of-the-art technologies to provide insights on the biomolecular mechanisms, pharmacokinetics, drug interactions; drug transport and metabolism.
早产儿视网膜病变(ROP)是所有极低胎龄新生儿(elgan, <28周/<1250g)中多达50%的患者。在elgan和动物模型中,布洛芬和咖啡因已被证明可以降低严重ROP的风险。使用我们实验室开发的独特技术,我们将检查对人类视网膜微血管内皮尖细胞(ECs)的特定影响,ECs是异常血管生成背后的驱动力。我们将研究它们与星形胶质细胞的动态相互作用,它们在氧化应激过程中的选择、激活和迁移。更重要的是,我们将研究布洛芬和/或咖啡因在阻止它们激活和降低它们感知血管生成信号的能力方面的功效。本研究的总体目标是研究EC尖端细胞在氧化应激(高氧/缺氧循环)环境下的行为及其与星形胶质细胞的关系;并确定布洛芬与咖啡因共同使用是否会保持细胞的静止。使用最先进的生物分析,蛋白质组学,药物基因组学,生物信息学和成像技术,我们将使用三个相互关联的特定目标:1)检查人类视网膜微血管内皮细胞和人类大脑星形胶质细胞在常氧和氧化应激(短暂高氧/缺氧循环)之间的关系。我们将重点关注VEGF和ECM蛋白水解,VEGF释放和梯度增加;尖端细胞的活化、VEGF的释放和再捕获以及迁移;VEGF和Notch信号机制;2)利用小干扰RNA确定VEGFR-2、VEGFR-3、NP-1、Notch 1、D1I4和Jagged 1在尖端细胞选择、激活和迁移中的作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kay Beharry其他文献
Kay Beharry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kay Beharry', 18)}}的其他基金
Ibuprofen-Caffeine Modulation of Retinal Endothelial Tip Cell Migration
布洛芬-咖啡因对视网膜内皮尖端细胞迁移的调节
- 批准号:
8260913 - 财政年份:
- 资助金额:
$ 24.13万 - 项目类别:
OCULAR NSAIDs/CAFFEINE POTENTIATION IN OXYGEN-INDUCED RETINOPATHY
眼部非甾体抗炎药/咖啡因对氧引起的视网膜病变的增强作用
- 批准号:
8260912 - 财政年份:
- 资助金额:
$ 24.13万 - 项目类别:
OCULAR NSAIDs/CAFFEINE POTENTIATION IN OXYGEN-INDUCED RETINOPATHY
眼部非甾体抗炎药/咖啡因对氧引起的视网膜病变的增强作用
- 批准号:
8379422 - 财政年份:
- 资助金额:
$ 24.13万 - 项目类别:
OCULAR NSAIDs/CAFFEINE POTENTIATION IN OXYGEN-INDUCED RETINOPATHY
眼部非甾体抗炎药/咖啡因对氧引起的视网膜病变的增强作用
- 批准号:
8473238 - 财政年份:
- 资助金额:
$ 24.13万 - 项目类别:
Ibuprofen-Caffeine Modulation of Retinal Endothelial Tip Cell Migration
布洛芬-咖啡因对视网膜内皮尖端细胞迁移的调节
- 批准号:
8379424 - 财政年份:
- 资助金额:
$ 24.13万 - 项目类别:
Ibuprofen-Caffeine Modulation of Retinal Endothelial Tip Cell Migration
布洛芬-咖啡因对视网膜内皮尖端细胞迁移的调节
- 批准号:
8473240 - 财政年份:
- 资助金额:
$ 24.13万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 24.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




